SCHEMBL31699656

SCHEMBL31699656

CC(C)(C)OC(=O)NCc1ccc(-c2cccc(=O)[nH]2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ HDAC1 Q13547 2/20 0.47
▸ MAP2K1 Q02750 1/20 0.46
▸ NAMPT P43490 2/20 0.46
▸ HPN P05981 1/20 0.45
▸ GAA P10253 1/20 0.43
▸ BRD4 O60885 1/20 0.42
▸ CREBBP Q92793 1/20 0.42
▸ SDCBP O00560 1/20 0.42
▸ SDC2 P34741 1/20 0.42
▸ AKT1 P31749 1/20 0.42
▸ NOTUM Q6P988 1/20 0.42
▸ BRS3 P32247 1/20 0.42
▸ PARP1 P09874 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3180689 0.79 L3MBTL1 (0.61) L3MBTL1HDAC1NAMPTGAASDCBP
SCHEMBL1691047 0.78 HDAC1 (0.67) L3MBTL1HDAC1NAMPTGAASDCBP
SCHEMBL31699229 0.78 L3MBTL1 (0.51) L3MBTL1HDAC1NAMPTHPNGAA
SCHEMBL31248761 0.77 L3MBTL1 (0.52) L3MBTL1HDAC1NAMPTHPNGAA
SCHEMBL16578887 0.76 PRMT5 (0.44) L3MBTL1HDAC1NAMPTHPNPARP1
SCHEMBL2567630 0.76 HDAC1 (0.57) L3MBTL1HDAC1NAMPTHPNGAA
SCHEMBL17279959 0.75 PRKD1 (0.56) L3MBTL1HDAC1NAMPTBRD4CREBBP
SCHEMBL99337 0.75 TPSAB1 (0.56) L3MBTL1HDAC1NAMPTGAACA1
SCHEMBL22400217 0.75 NAMPT (0.50) L3MBTL1HDAC1NAMPTHPNGAA
SCHEMBL3838871 0.75 CA12 (0.63) L3MBTL1HDAC1NAMPTAKT1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320213-A1 Nitrogen-Containing Heterocyclic Compounds PFIZER INC. (US) 2025-10-16 — — US disclosed
WO-2025215579-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2025-10-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320213-A1 Nitrogen-Containing Heterocyclic Compounds HRH4, HNMT, NNT L3MBTL1 3402/4885HDAC1 728/4885MAP2K1 2627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback